Janus Henderson Group PLC Sells 462,468 Shares of Doximity, Inc. $DOCS

Key Points

• Janus Henderson sharply reduced its Doximity stake by selling 462,468 shares, an 89.3% decrease, leaving it with 55,690 shares valued at approximately $1.3 million.
• Doximity reported fiscal Q1 revenue of $156.6 million, up 7.3% year over year, and adjusted EPS of $0.29. Management raised fiscal 2027 revenue guidance to $671 million-$681 million, citing pharmaceutical demand and growing AI adoption.
• Investor sentiment remains mixed: AI investment is pressuring earnings compared with last year, while analyst targets range widely. The stock carries a consensus “Hold” rating and a $31.86 average price target.

Janus Henderson Group PLC cut its holdings in shares of Doximity, Inc. (NYSE:DOCS - Free Report) by 89.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 55,690 shares of the company's stock after selling 462,468 shares during the period. Janus Henderson Group PLC's holdings in Doximity were worth $1,297,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Doximity by 0.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company's stock valued at $2,262,000 after acquiring an additional 210 shares during the last quarter. BOKF NA raised its holdings in shares of Doximity by 5.3% during the third quarter. BOKF NA now owns 5,356 shares of the company's stock valued at $392,000 after purchasing an additional 269 shares during the last quarter. Northwestern Mutual Investment Management Company LLC raised its holdings in shares of Doximity by 1.1% during the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 30,736 shares of the company's stock valued at $1,361,000 after purchasing an additional 333 shares during the last quarter. Lifestyle Asset Management Inc. raised its holdings in shares of Doximity by 5.9% during the fourth quarter. Lifestyle Asset Management Inc. now owns 7,083 shares of the company's stock valued at $314,000 after purchasing an additional 396 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its position in Doximity by 99.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company's stock valued at $35,000 after purchasing an additional 397 shares during the period. 87.19% of the stock is currently owned by institutional investors.

Doximity News Summary

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Doximity reported fiscal Q1 revenue of $156.6 million, up 7.3% year over year, and adjusted earnings of $0.29 per share. Revenue exceeded expectations, while the company’s profitability and 30.4% net margin remained notable. Doximity earnings report
• Positive Sentiment: Management raised fiscal 2027 revenue guidance to $671 million-$681 million, slightly above the analyst consensus of $670.4 million. The outlook reflects anticipated demand from pharmaceutical customers and continued adoption of Doximity’s AI capabilities. Doximity Q1 earnings and guidance
• Positive Sentiment: The CEO said Doximity’s clinical AI search generates roughly 10 times more revenue than it costs to operate, while AI-driven engagement is outperforming expectations. Investors view this as a potential source of future monetization that is not fully reflected in current forecasts. CNBC Doximity AI report
• Positive Sentiment: Analysts raised their targets: Piper Sandler maintained an overweight rating and lifted its target to $47 from $42, while JPMorgan raised its target to $31 from $26 but retained a neutral rating. Analyst target changes
• Neutral Sentiment: Doximity’s addition or reclassification within the Russell 1000 may broaden institutional visibility and affect index-related trading, but it does not directly change the company’s fundamentals. Russell 1000 reclassification
• Negative Sentiment: Adjusted earnings fell from $0.36 per share a year earlier, and some estimates showed a slight earnings miss. Higher AI investment is pressuring margins, while critics argue the rally may have moved ahead of near-term fundamentals and could reverse. Doximity rally analysis

Analysts Set New Price Targets

Several equities research analysts recently issued reports on DOCS shares. Wells Fargo & Company restated an "equal weight" rating and issued a $18.00 target price (down from $32.00) on shares of Doximity in a report on Thursday, May 14th. Zacks Research raised Doximity from a "strong sell" rating to a "hold" rating in a report on Monday, July 13th. Piper Sandler reissued an "overweight" rating and set a $47.00 price target (up from $42.00) on shares of Doximity in a report on Friday. Morgan Stanley dropped their price target on Doximity from $49.00 to $35.00 and set an "overweight" rating on the stock in a research note on Thursday, May 14th. Finally, Truist Financial reaffirmed a "hold" rating and issued a $19.00 price objective (down from $29.00) on shares of Doximity in a report on Thursday, May 14th. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, thirteen have issued a Hold rating and three have given a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $31.86.

Insider Buying and Selling

In other Doximity news, insider Siddharth Sitaram sold 2,444 shares of the firm's stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $20.41, for a total transaction of $49,882.04. Following the sale, the insider directly owned 90,706 shares of the company's stock, valued at $1,851,309.46. This trade represents a 2.62% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 31.80% of the stock is currently owned by corporate insiders.

Doximity Price Performance

DOCS opened at $27.35 on Monday. The firm has a market cap of $5.00 billion, a P/E ratio of 32.18, a PEG ratio of 9.94 and a beta of 1.29. Doximity, Inc. has a 1-year low of $17.15 and a 1-year high of $76.51. The company has a 50 day simple moving average of $21.28 and a two-hundred day simple moving average of $24.25.

Doximity (NYSE:DOCS - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.16 by $0.13. Doximity had a net margin of 25.48% and a return on equity of 18.06%. The firm had revenue of $156.62 million for the quarter. During the same quarter in the previous year, the business earned $0.36 earnings per share. The firm's revenue for the quarter was up 7.3% on a year-over-year basis. Equities analysts anticipate that Doximity, Inc. will post 0.87 earnings per share for the current year.

About Doximity

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NYSE:DOCS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source